Literature DB >> 30760847

Function and mechanisms of enteroendocrine cells and gut hormones in metabolism.

Fiona M Gribble1, Frank Reimann2.   

Abstract

Gut hormones have many key roles in the control of metabolism, as they target diverse tissues involved in the control of intestinal function, insulin secretion, nutrient assimilation and food intake. Produced by scattered cells found along the length of the intestinal epithelium, gut hormones generate signals related to the rate of nutrient absorption, the composition of the luminal milieu and the integrity of the epithelial barrier. Gut hormones already form the basis for existing and developing therapeutics for type 2 diabetes mellitus and obesity, exemplified by the licensed glucagon-like peptide 1 (GLP1) mimetics and dipeptidyl peptidase inhibitors that enhance GLP1 receptor activation. Modulating the release of the endogenous stores of GLP1 and other gut hormones is thought to be a promising strategy to mimic bariatric surgery with its multifaceted beneficial effects on food intake, body weight and blood glucose levels. This Review focuses on the molecular mechanisms underlying the modulation of gut hormone release by food ingestion, obesity and the gut microbiota. Depending on the nature of the stimulus, release of gut hormones involves recruitment of a variety of signalling pathways, including G protein-coupled receptors, nutrient transporters and ion channels, which are targets for future therapeutics for diabetes mellitus and obesity.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30760847     DOI: 10.1038/s41574-019-0168-8

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  105 in total

1.  5-HT containing enteroendocrine cells characterised by morphologies, patterns of hormone co-expression, and relationships with nerve fibres in the mouse gastrointestinal tract.

Authors:  Ada Koo; Linda J Fothergill; Hirofumi Kuramoto; John B Furness
Journal:  Histochem Cell Biol       Date:  2021-02-19       Impact factor: 4.304

Review 2.  Novel therapies with precision mechanisms for type 2 diabetes mellitus.

Authors:  Leigh Perreault; Jay S Skyler; Julio Rosenstock
Journal:  Nat Rev Endocrinol       Date:  2021-05-04       Impact factor: 43.330

3.  In focus in HCB.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2021-06-07       Impact factor: 4.304

4.  Role of Enteroendocrine Hormones in Appetite and Glycemia.

Authors:  Maria Laura Ricardo-Silgado; Alison McRae; Andres Acosta
Journal:  Obes Med       Date:  2021-03-12

Review 5.  Metabolic Messengers: glucagon-like peptide 1.

Authors:  Fiona M Gribble; Frank Reimann
Journal:  Nat Metab       Date:  2021-01-11

Review 6.  Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation.

Authors:  Han Xie; Natesh Yepuri; Qinghe Meng; Ravi Dhawan; Colin A Leech; Oleg G Chepurny; George G Holz; Robert N Cooney
Journal:  Rev Endocr Metab Disord       Date:  2020-08-26       Impact factor: 6.514

Review 7.  Leveraging the Gut to Treat Metabolic Disease.

Authors:  Ruth E Gimeno; Daniel A Briere; Randy J Seeley
Journal:  Cell Metab       Date:  2020-03-17       Impact factor: 27.287

8.  Bye, bye, bile: how altered bile acid composition changes small intestinal lipid sensing.

Authors:  Frank A Duca; Tony K T Lam
Journal:  Gut       Date:  2020-04-17       Impact factor: 23.059

Review 9.  A Role for GLP-1 in Treating Hyperphagia and Obesity.

Authors:  Harvey J Grill
Journal:  Endocrinology       Date:  2020-08-01       Impact factor: 4.736

Review 10.  Microbiota impacts on chronic inflammation and metabolic syndrome - related cognitive dysfunction.

Authors:  María Arnoriaga-Rodríguez; José Manuel Fernández-Real
Journal:  Rev Endocr Metab Disord       Date:  2019-12       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.